-
Sector Analysis
NewUnited Kingdom (UK) Critical Illness Insurance Distribution Dynamics and Future Market
United Kingdom (UK) Critical Illness Insurance Market Report Overview The COVID-19 pandemic has left a lasting impact on consumers, highlighting the importance of mental and physical well-being and boosting awareness around the advantages of critical illness coverage. The total critical illness insurance market premiums was GBP28.7 million in 2022 and it will grow at a CAGR of more than 7% from 2022 to 2027. The UK critical illness insurance market research report explores consumer purchasing behaviors for critical illness insurance...
-
Product Insights
NewLikelihood of Approval Analysis for Insomnia
Overview How likely is it that the drugs in Insomnia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Insomnia Overview Insomnia is a sleep disorder that is characterized by difficulty falling...
-
Product Insights
NewLikelihood of Approval Analysis for Anxiety Disorders
Overview How likely is it that the drugs in Anxiety Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anxiety Disorders Overview Anxiety disorders are a group of mental health conditions...
-
Product Insights
NewLikelihood of Approval Analysis for Prader-Willi Syndrome (PWS)
Overview How likely is it that the drugs in Prader-Willi Syndrome (PWS) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Prader-Willi Syndrome (PWS) Overview Prader-Willi syndrome (PWS) is a rare congenital...
-
Product Insights
NewLikelihood of Approval Analysis for Obstructive Sleep Apnea
Overview How likely is it that the drugs in Obstructive Sleep Apnea will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Obstructive Sleep Apnea Overview Obstructive sleep apnea (OSA) is defined by...
-
Product Insights
NewLikelihood of Approval Analysis for Bipolar Disorder (Manic Depression)
Overview How likely is it that the drugs in Bipolar Disorder (Manic Depression) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bipolar Disorder (Manic Depression) Overview Bipolar disorder, previously known as...
-
Product Insights
NewLikelihood of Approval Analysis for Depression
Overview How likely is it that the drugs in Depression will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Depression Overview Depression is a mental state of low mood and aversion to...
-
Product Insights
NewLikelihood of Approval Analysis for Psychosis
Overview How likely is it that the drugs in Psychosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psychosis Overview Psychosis is a condition that affects the mind and causes a...
-
Product Insights
NewLikelihood of Approval Analysis for Major Depressive Disorder
Overview How likely is it that the drugs in Major Depressive Disorder will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Major Depressive Disorder Overview Major Depressive Disorder (MDD) is a common...
-
Product Insights
NewLikelihood of Approval Analysis for Bipolar I Disorder
Overview How likely is it that the drugs in Bipolar I Disorder will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bipolar I Disorder Overview Bipolar I Disorder is a mental health...